Formulation and evaluation of floating microsphere containing anti-diabetic (metformin hydrochloride) drug

International Journal of PharmTech Research

Volumn 2, Issue 1, 2010, Pages 378-384

  Ghodake, J D ^a   Vidhate, J S ^a   Shinde, D A ^b   Kadam, A N ^c  

^a NANDHA COLLEGE OF PHARMACY   (India)

^b UNIVERSITY OF SKÖVDE   (Sweden)

^c LONDON METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Bioavability; Emulsion solvent diffusion technique; Floating microsphere; In vitro release; Metformin hydrochloride; Methacrylic acid copolymer (Eudragit RS100)

Indexed keywords

ANTIDIABETIC AGENT; METFORMIN; MICROSPHERE; POLYMER;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; HUMAN; IN VITRO STUDY; INFRARED SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY;

EID: 77953398180     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Williams D,A., Lemke, T.L., Williams, L., 2002. Insulin and Oral Hypoglyecemic drugs. In: Foye's Principles of Medicinal Chemistry, 5th ed, New York Lippincott Williams and Wilkins., 641-648.
2. Stepensky, D., Friedman, M., Srour, W., Raz, I., Hoffman, A., 2001. Preclinical evaluation of pharmacokinetic and pharmacodynamic rationale for oral CR metformin formulation. J.Control. Release 71, 107-115.
3. Noel M., Kinetic study of normal and sustained release dosage forms of metformin in normal subjects, J. Int. Biomed Data 1980., 1. 9-20.
4. Pentikainen, P., 1986. Bioavailability of metformin. Comparison of solution, rapidly dissolving tablet, and three sustained release products. Int. J. Clin Pharmacol Ther Toxicol 24 ,4, 213-220.
5. Yuen, K. H., Peh, K. K., Tan B.L., 1999. Relating in vitro/ in vivo data of two controlled release metformin formulations, Drug Dev Ind. Pharm 25 ,(5), 613-618.
6. Fujioka, K., Ledger, G., Stevens, J., Goyvaerts, H., Jamoul, C., Stein, P., 2000. Once daily dosing of metformin extended release (Met-XR) formulation: effects on glycemic control in patients with type 2 diabetes currently treated with metformin, In: American Diabetes Association, 60th Scientific Sessions, San Antonio, Texas.
7. Gusler, G., Berner, B., 2000. Metformin (GR) gastric retentive tablets: GI transit and pharmacokinetics in healthy volunteers, In: Millennial World Congress of Pharmaceutical Science, San Francisco, California.
8. Metformin info (www.Rxlist.com ; accessed 5/10/2005).
9. Vidon, N., Chaussade, S., Noel, M., Franchisseu,r C., Huchet, B., Bernier, J. J., 1998. Metformin in the digestive tract. Diabetes Res Clin Pract 4, 223-229.
10. Marathe, P.H., Wen, Y., Norton, J., Greene, D.S., Barbhaiya, R.H., Wilding, I.R; 1999. Effect of altered gastric emptying and gastrointestinal motility on bioavailability of metformin, in: AAPS Annual Meeting, New Orleans, LA.
11. El-Kamel, A.H., Sokar, M.S., Al Gamal, S.S., Naggar, V.F., 2001. Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm 220, 13-21.
12. Iannuccelli, V., Coppi, G., Bernabei, M.T., Cameroni, R., 1998. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int. J. Pharm 174, 47-54.
13. Acikgoz, M., Kas, H.S., Hascelik, Z., Milli, U., Hincal, A.A., 1995. Chitosan microspheres of diclofenac sodium, II: In vitro and in vivo evaluation. Pharmazie 50, 275-277.
14. Thanoo, B.C., Sunny, M.C., Jayakrishna, A., 1993.Oral sustained -release drug delivery system using polycarbonate microspheres capable of floating on the gastric fluid. J. Pharm. Pharmacol 45, 21-24.
15. Streubel, A., Siepmann, J., Bodmeier, R., 2002. Floating microparticles based on low density foam powder. Int. J. Pharm 241, 279-292.
16. Streubel, A., Siepmann, J., Bodmeier, R., 2003. Multiple unit gastroretentive drug delivery systems: a new preparation method for low-density microparticles. J. Microencapsulation. 20,(3), 329-347.
17. Jayanthi, G., Jayaswal, S.B., Srivastava, A.K., 1995. Formulation and evaluation of terfenadine microballoons for oral controlled release. Pharmazie 50, 769-770.
18. Sato, Y., Kawashima, Y., Takeuchi, H., Yamamoto, H., 2003. In vivo evaluation of riboflavincontaining microballoons for floating controlled drug delivery system in healthy human volunteers. J. Control. Release 93, 39-47.
19. Deasy, P. B; 1984. Microencapsulation and related drug processes, Marcel Dekker Inc.
20. Benita, S., 1996. Microencapsulation: methods and industrial applications. Vol. 73, Mercel Dekker, Inc.
21. Rao, K.R., Senapati, P., Das, M.K., 2005. Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J. Microencapsulation 22,(8), 863-876.
22. Srivastava, A.K., Ridhurkar, D.N., Wadha., 2005.Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation. Acta Pharm 55,(3), 277-285.
23. Wu, P.C., Huang, Y.B., Chang, J.I., Tsai, M.J., Tsai, Y.H., 2003. Preparation and evaluation of sustained release microspheres of potassium chloride preapred with ethylcellulose. Int. J. Pharm 260,(1), 115- 121.
24. Dinarvand, R., Mirfattahi, S., Atyabi, F., 2002. Preparation, characterization and in vitro drug release of isosorbide dinitrate microspheres. J. Microencapsulation 19,(1), 73-81.
25. Ray, S., Ghosh, P.K., Das, B., Ghosh, L.K., Gupta, B.K., 2000. Statistical optimization supported product development of anti-asthamatic multiparticulate drug delivery system. Indian .J. Pharm Sci 62,(3), 175-180.
26. Barik, B.B., Ray, S,. Goswami, N., Gupta, B.K., Ghosh, L.K., 2001. Preparation and in vitro dissolution of Isoniazid from ethylcellulose microcapsules. Acta Poloniae Pharm 28,(1), 65-68.
27. Jain, S.K., Awasthi, A.M,. Jain, N.K., Agrawal G.P; 2005. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization.; J Control. Release 8:8.
28. Rouge, N,. Allemann, E., Gex-Fabry, M., Balant, L., Cole, E.T., Buri, P., 1998.Comparatie pharmacokinetics study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 ng atenolol. Pharm Acta Helv 73,(2), 81-87.
29. El-Gibaly, I., 2002. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int. J. Pharm 249,(1-2), 7-21.
30. Reddy, L.H.V., Murthy, R.S.R., 2002. Floating dosage systems in drug delivery. Crit Rev Ther Drug Carrer Syst 19,(6), 553-585.
31. Talukdar, R., Fassihi, R., 2004. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 30,(10), 1019-1028.
32. Soppimath, K.S., Kulkarni, A.R., Rudzinski, W.E., Aminabhavi, T.M., 2001. Microspheres as floating drugdelivery systems to increase gastric retention of drugs. Drug Metab Rev 33,(2), 149-160.
33. Gouldson, M.P., Deasy, P.B., 1997. Use of cellulose ether containing excipients with microcrystalline cellulose for the production of pellets containing metformin hydrochloride by the process of extrusion-spheronizatioin. J. Microencapsulation 14,(2), 137-153.
34. Hoffman,A., Stepensky, D., Lavy, Eyal ,S., Klausner, E., Friedman, M., 2004.Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int. J. Pharm 277(1-2), 141-153.
35. Martin, A., Bustamate, P., Chun, A.H.C., 1999. Micromeritics. In: Physical pharmacy. 4th ed. BI Waverly Pvt. Ltd.
36. Lee, J.H., Park, T.G., Choi, H.K., 1999.Development of oral drug delivery system using floating microspheres. J Microencapsulation 16,(6), 715-729.
37. USP 26, NF 21. Asian Edition. United states Pharmacopoeial Convention Inc; 2003.
38. James,E., Polli, G., Singh, Rekhi., Vinod, P., Shah., 1996.Methods to compare dissolution profiles. Drug Information Journal; 30, 1113-1120.